| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 311,648 | | Cost of Revenue | 179,480 | | | Gross Profit | 132,168 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 20,086 | | Non Recurring | 9,354 | | Others | 33,011 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 69,717 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,848 | | Earnings Before Interest And Taxes | 80,565 | | Interest Expense | 1,512 | | Income Before Tax | 79,053 | | Income Tax Expense | 13,777 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 65,276 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 65,276 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $65,276 |
|
0.34% Nasdaq 0.00%
Income Statement
